Taken together, we found that treating tumor-bearing mice with a STING agonist induced CAFs with a more pronounced ifCAF phenotype at the expense of the myCAF population, gave rise to a polarization of TANs toward an antitumor phenotype, and led to the suppression of EMT in tumors. The gene discussed is STING1; the disease is neoplasm.